Company Overview
Aesica Formulation Development Limited is a Dissolved Private Limited Company.
Registered Address

Aesica Formulation Development Limited Windmill Industrial Estate, Shotton Lane, Cramlington, Northumberland, NE23 3JL
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameAESICA FORMULATION DEVELOPMENT LIMITED
Company Number05661235
Registered Office AddressAesica Formulation Development Limited Windmill Industrial Estate
 Shotton Lane
 NE23 3JL
Company CategoryPrivate Limited Company
Company StatusDissolved
Country of OriginUnited Kingdom
Incorporation Date22/12/2005
Accounting Reference Date Day30
Accounting Reference Date Month4
Accounts Next Due Date31/01/2021
Accounts Last Made Up Date31/01/2020
Accounts Account CategoryFULL
Returns Next Due Date19/01/2017
Returns Last Made Up Date22/12/2015
Previous Company NameChanged Date
R5 PHARMACEUTICALS LIMITED16 Feb 2012
R5 LIMITED14 Aug 2006
Directors & Members
Show Resigned
Thomas Eldered - Director
(Swedish, 66 years old, born October 1960)
Appointed 04 February 2020
 Active
Mark Quick - Director
(British, 60 years old, born May 1966)
Appointed 15 June 2020
 Active
Secretaries
Show Resigned
Other Company Directorships
Thomas Eldered
AESICA BC LIMITED
AESICA HOLDCO LIMITED
AESICA M1 LIMITED
AESICA M2 LIMITED
AESICA QUEENBOROUGH LIMITED
AESICA TRUSTEE COMPANY LIMITED
BESPAK EUROPE LIMITED
BESPAK FINANCE LIMITED
BESPAK HC LIMITED
CONSORT MEDICAL FINANCE 2010 LIMITED
CONSORT MEDICAL FINANCE LIMITED
CONSORT MEDICAL HOLDINGS LIMITED
CONSORT MEDICAL LIMITED
HYPERLYSER LIMITED
INTEGRATED ALUMINIUM COMPONENTS LIMITED
MEDICAL HOUSE (ASI) LIMITED
MEDICAL HOUSE PRODUCTS LIMITED
PHARMARON MANUFACTURING SERVICES (UK) LTD
THE MEDICAL HOUSE GROUP LIMITED
THE MEDICAL HOUSE LIMITED
Mark Quick
AESICA BC LIMITED
AESICA HOLDCO LIMITED
AESICA M1 LIMITED
AESICA M2 LIMITED
AESICA QUEENBOROUGH LIMITED
AESICA TRUSTEE COMPANY LIMITED
BESPAK EUROPE LIMITED
BESPAK FINANCE LIMITED
BESPAK HC LIMITED
BINX HEALTH LIMITED
CONSORT MEDICAL FINANCE 2010 LIMITED
CONSORT MEDICAL FINANCE LIMITED
CONSORT MEDICAL HOLDINGS LIMITED
CONSORT MEDICAL LIMITED
FLERIE INVEST LTD
MICROBIOTICA LIMITED
PHARMARON MANUFACTURING SERVICES (UK) LTD
PULLWOOD HOUSE MANAGEMENT COMPANY LIMITED
RECIPHARM LIMITED
RECIPHARM PROPERTIES LIMITED
RECIPHARM STERILES LIMITED
RECIPHARM UK LIMITED
SPEED CHESHIRE LIMITED
THE MEDICAL HOUSE LIMITED
Balance Sheet Unlock full report
Accounts Date 31-Jan-2020 31-Dec-2011 31-Dec-2010
Balance Sheet
Fixed Assets 507,000 507,000 504,413
Current Assets 2,155,000 2,155,000 1,233,267
Creditors Due Within One Year 1,166,000 1,166,000 806,591
Working Cap 989,000 989,000 426,676
Total Assets Less Current Liabilities 1,496,000 1,496,000 931,089
Long-term Liabilities 0 0 214,262
Net Assets 1,496,000 1,496,000 716,827
Share Capital & Reserves
Share Cap 4,000 4,000 2,131
Profit & Loss Reserves 1,108,000 1,108,000 498,341
Other Reserves 384,000 384,000 216,355
Shareholders Funds 1,496,000 1,496,000 716,827
Common Size Financial Analysis Unlock full report
Accounts Date 31-Jan-2020 31-Dec-2011 31-Dec-2010
Tangible Fixed Assets - - -
Fixed Assets 19.0% 19.0% 29.0%
Stocks Inventory 4.0% 4.0% 0.0%
Debtors 66.4% 66.4% 35.4%
Cash Bank In Hand 10.6% 10.6% 35.6%
Current Assets 81.0% 81.0% 71.0%
Creditors Due Within One Year 43.8% 43.8% 46.4%
Net Current Assets Liabilities 37.2% 37.2% 24.6%
Creditors Due After One Year 0.0% 0.0% 12.0%
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability 56.2% 56.2% 41.3%
Called Up Share Capital 0.2% 0.2% 0.1%
Share Capital Allotted Called Up Paid 0.2% 0.2% 0.1%
Profit Loss Account Reserve 41.6% 41.6% 28.7%
Shareholder Funds 56.2% 56.2% 41.3%
Capital Employed - - -
Total Assets Less Current Liabilities 56.2% 56.2% 53.6%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Jan-2020 31-Dec-2011 31-Dec-2010
Liquidity Ratio 1.8 1.8 1.5
Solvency Ratio 2.3 2.3 1.7
Reserves to Assets 0.4 0.4 0.3
Secured Creditors Unlock full report
Mortgages Charges 10
Mortgages Outstanding 1
Mortgages Part Satisfied 0
Mortgages Satisfied 9
Assets and Debt Analysis Unlock full report
Accounts Date 31-Jan-2020 31-Dec-2011 31-Dec-2010
Assets 2,662,000 2,662,000 1,737,680
Debt 1,166,000 1,166,000 1,020,853
Net Assets/Debt 1,496,000 1,496,000 716,827
Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around NE23 3JL
No other companies found in the same location
Document Filings
Final Gazette dissolved via voluntary strike-off
First Gazette notice for voluntary strike-off
Application to strike the company off the register
Confirmation statement made on 22 December 2020 with updates
Statement by Directors
Statement of capital on 14 October 2020
Solvency Statement dated 11/10/20
Resolutions
Register inspection address has been changed from C/O Consort Medical Plc Breakspear Park Breakspear Way Hemel Hempstead Hertfordshire HP2 4TZ England to Aesica Formulation Development Limited Windmill Industrial Estate Shotton Lane Cramlington Northumberland NE23 3JL
Registered office address changed from Suite B Breakspear Park Breakspear Way Hemel Hempstead Hertfordshire HP2 4TZ England to Aesica Formulation Development Limited Windmill Industrial Estate Shotton Lane Cramlington Northumberland NE23 3JL on 24 July 2020
Change of details for Aesica Queenborough Limited as a person with significant control on 23 April 2020
Appointment of Mr Mark Royston Quick as a director on 15 June 2020
Termination of appointment of Andrew Leonard Jackson as a secretary on 30 April 2020
Previous accounting period shortened from 30 April 2020 to 31 January 2020
Termination of appointment of Paul Andrew Hayes as a director on 4 February 2020
Termination of appointment of Jonathan Martin Glenn as a director on 4 February 2020
Appointment of Mr Thomas Eldered as a director on 4 February 2020
Confirmation statement made on 22 December 2019 with no updates
Termination of appointment of Manja Hermina Elisabeth Maria Boerman as a director on 30 November 2019
Confirmation statement made on 22 December 2018 with no updates
Appointment of Mr Andrew Leonard Jackson as a secretary on 7 September 2018
Termination of appointment of Paul Andrew Hayes as a secretary on 7 September 2018
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free